NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

New Publication: Reaksi Drug Safety News - July 2016

User Rating: 3 / 5

Star ActiveStar ActiveStar ActiveStar InactiveStar Inactive
 

REAKSI Drug Safety News,

No. 30 ,July 2016

 

  • Concomitant Use of Spironolactone and Renin-Angiotensin System Drugs in Heart Failure: Risk of Potentially Fatal Hyperkalaemia
  • Noxafil® (posaconazole): Tablet and Oral Suspension Not Interchangeable

 



 
 
  DOWNLOAD PDF


 

 

 

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

  • Last Modified: Tuesday 08 October 2024, 14:10:53.

Search

Main Menu English